Session » Patient Perspectives Poster

Date: Sunday, November 12, 2023

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2023

Abstract Number: PP01

You Can’t Get This from a Doctor: The Role of Support Groups for Adults Aged 25-55 Living with Arthritis

Abstract Number: PP02

Patient Centered Care: The Complete Picture

Abstract Number: PP03

Lupus with Slime: Improve QOL and Increase ROM in SLE with Slime

Abstract Number: PP04

Bouncing Back: How I Found My Running Shoes Using a Rebounder for My Psoriatic Arthritis

Abstract Number: PP05

Relief Redefined: A Patient’s Journey to Reducing the Impact of Her PsA Flare Ups

Abstract Number: PP06

Dana’s Data Dashboard: Applying a Familiar Framework for Efficient and Effective Health Management

Abstract Number: PP07

How “Coming Out” About My Lupus Diagnosis Allowed Me to Connect With Patients, Get Involved With Research, and Spread Awareness

Abstract Number: PP08

Finding Gratitude in Adversity: The Impact of Finding the Right Rheumatologist

Abstract Number: PP09

Practicing Mindfulness to Improve Quality of Life

Abstract Number: PP10

Saved by Plants: How a Necessary Lifestyle Change Led to a Happier Life with Decreased Rheumatoid Arthritis Pain and Fatigue

Abstract Number: PP11

We Suffered For Decades, But Then She Was Born

Abstract Number: PP12

Sjögren’s-Fatigue: Non-Therapeutic Lifestyle Adjustments to Help Manage My Most Problematic Symptom

Abstract Number: PP13

My Four Pillars of Wellness: How Sleep, Diet, Exercise and Stress Reduction Enable Me to Define My Life and not let Sjögren’s Define Me

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.